Vitiligo progression in a patient undergoing romosozumab treatment for osteoporosis
Saved in:
Main Authors: | Nicole Trepanowski, MD (Author), Rebecca M. Yim, BA (Author), Rachel Wetstone, MPH (Author), Elizabeth MacDonald, BS (Author), Sarah Servattalab, MD (Author), Subin Jacob-George, PA (Author), John E. Harris, MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Profile of romosozumab and its potential in the management of osteoporosis
by: Lim SY, et al.
Published: (2017) -
Clinical Utility of Romosozumab in the Management of Osteoporosis: Focus on Patient Selection and Perspectives
by: Lim SY, et al.
Published: (2022) -
Vitiligo of the arm after COVID-19 vaccination
by: Rhea Singh, BS, et al.
Published: (2022) -
A folliculocentric variant of extragenital lichen sclerosus presenting in a 29-year-old man
by: Rachel Wetstone, MPH, et al.
Published: (2023) -
Social media dermatologic advice: Dermatology without dermatologists
by: Nicole Trepanowski, BS, et al.
Published: (2023)